Beauty Farm Medical & Health Industry (FRA:XC5) Beneish M-Score: -3.01 (As of Jun. 26, 2026)


FRA:XC5 Beauty Farm Medical & Health Industry Inc FRA:XC5
85 GF Score
Price €1.73
GF Value €2.96
! 2 Warning Signs
View Full Analysis

What is Beauty Farm Medical & Health Industry Beneish M-Score?

Beauty Farm Medical & Health Industry FRA:XC5 -1.70% 85 Beneish M-Score is -3.01 as of Jun. 26, 2026. GuruFocus rates FRA:XC5 with a GF Score™ of 85/100 and a GF Value™ of €2.96. The stock has 2 warning signs investors should review. Among 633 Healthcare Providers & Services companies, Beauty Farm Medical & Health Industry ranks better than 78.83% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.01 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Beauty Farm Medical & Health Industry's Beneish M-Score or its related term are showing as below:

FRA:XC5' s Beneish M-Score Range Over the Past 10 Years
Min: -3.38   Med: -2.89   Max: -2.33
Current: -3.01

During the past 7 years, the highest Beneish M-Score of Beauty Farm Medical & Health Industry was -2.33. The lowest was -3.38. And the median was -2.89.


Beauty Farm Medical & Health Industry Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Beauty Farm Medical & Health Industry's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beauty Farm Medical & Health Industry Beneish M-Score Chart

Beauty Farm Medical & Health Industry Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -2.33 -2.52 -3.38 -2.89 -3.01

Beauty Farm Medical & Health Industry Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.38 0.00 -2.89 0.00 -3.01

FRA:XC5 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Beauty Farm Medical & Health Industry's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beauty Farm Medical & Health Industry Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beauty Farm Medical & Health Industry's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Beauty Farm Medical & Health Industry's Beneish M-Score falls into.


FRA:XC5
85GF Score
Beauty Farm Medical & Health Industry Inc FRA:XC5
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beauty Farm Medical & Health Industry Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Beauty Farm Medical & Health Industry for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9767+0.528 * 0.9431+0.404 * 0.9846+0.892 * 1.0783+0.115 * 0.8926
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0312+4.679 * -0.135058-0.327 * 1.0248
=-3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €10.3 Mil.
Revenue was €363.8 Mil.
Gross Profit was €178.5 Mil.
Total Current Assets was €346.5 Mil.
Total Assets was €611.9 Mil.
Property, Plant and Equipment(Net PPE) was €98.4 Mil.
Depreciation, Depletion and Amortization(DDA) was €49.1 Mil.
Selling, General, & Admin. Expense(SGA) was €29.0 Mil.
Total Current Liabilities was €352.8 Mil.
Long-Term Debt & Capital Lease Obligation was €120.7 Mil.
Net Income was €38.5 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €121.1 Mil.
Total Receivables was €9.8 Mil.
Revenue was €337.4 Mil.
Gross Profit was €156.1 Mil.
Total Current Assets was €286.7 Mil.
Total Assets was €560.9 Mil.
Property, Plant and Equipment(Net PPE) was €118.7 Mil.
Depreciation, Depletion and Amortization(DDA) was €50.2 Mil.
Selling, General, & Admin. Expense(SGA) was €26.0 Mil.
Total Current Liabilities was €359.3 Mil.
Long-Term Debt & Capital Lease Obligation was €64.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(10.331 / 363.82) / (9.809 / 337.392)
=0.028396 / 0.029073
=0.9767

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(156.09 / 337.392) / (178.468 / 363.82)
=0.462637 / 0.490539
=0.9431

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (346.527 + 98.37) / 611.861) / (1 - (286.737 + 118.736) / 560.94)
=0.272879 / 0.277154
=0.9846

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=363.82 / 337.392
=1.0783

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(50.182 / (50.182 + 118.736)) / (49.076 / (49.076 + 98.37))
=0.297079 / 0.33284
=0.8926

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(28.965 / 363.82) / (26.049 / 337.392)
=0.079614 / 0.077207
=1.0312

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((120.685 + 352.786) / 611.861) / ((64.327 + 359.253) / 560.94)
=0.773821 / 0.755125
=1.0248

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(38.505 - 0 - 121.142) / 611.861
=-0.135058

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Beauty Farm Medical & Health Industry has a M-score of -3.13 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.01 mean?
Beauty Farm Medical & Health Industry (FRA:XC5) has a Beneish M-Score of -3.01 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Beauty Farm Medical & Health Industry and its competitors. According to the industry distribution chart, Beauty Farm Medical & Health Industry ranks #134 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 21.2%.
Is Beauty Farm Medical & Health Industry's Beneish M-Score too high?
Beauty Farm Medical & Health Industry's current Beneish M-Score is -3.01. Based on the distribution chart, Beauty Farm Medical & Health Industry ranks #134 out of 633 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Beauty Farm Medical & Health Industry ranks #134 out of 633 companies for Beneish M-Score. This places Beauty Farm Medical & Health Industry in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Beauty Farm Medical & Health Industry and its competitors. Beauty Farm Medical & Health Industry's current Beneish M-Score is -3.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current Beneish M-Score of -3.01. The stock's GF Value™ is €2.96, compared to a current price of €1.73 — trading 41.6% below its estimated fair value. The current Beneish M-Score is -3.01. Beauty Farm Medical & Health Industry's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current Beneish M-Score is -3.01 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?

Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued. The current stock price of €1.73 is trading 41.6% below its estimated GF Value™ of €2.96.

Key valuation signals for FRA:XC5:

  • Beneish M-Score: -3.01
  • GF Value™: €2.96 vs. price of €1.73 (41.6% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beauty Farm Medical & Health Industry Business Description

Other Exchanges 02373:Hong Kong
Address No. 1089 Dongdaming Road, Unit 1206, 12th Floor, Hongkou District, Shanghai, CHN
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
85GF Score

Get the complete analysis for FRA:XC5

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.73
Price
€2.96
GF Value